cetylpyridinium chloride anhydrous has been researched along with Dyslipidemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, CY; Chen, YL; Chou, CC; Liao, YH; Sung, YC | 1 |
| Marais, AD | 1 |
| Anagnostopoulou, E; Karampatsis, P; Papanastasopoulou, C; Papassotiriou, I; Papastamataki, M; Sitaras, N | 1 |
| Bell, JA; Hamer, M; Kivimäki, M; Sabia, S; Singh-Manoux, A | 1 |
| Arner, E; Arner, P; Bernard, S; Buchholz, BA; Eriksson, M; Frayn, KN; Hauner, H; Liebl, J; Possnert, G; Rydén, M; Salehpour, M; Skurk, T; Spalding, KL; Steier, P | 1 |
| Hirata, M; Hosoda, K; Ida, M; Kasahara, M; Miyawaki, T; Nakao, K; Nakao, YM; Tanaka, S; Ueshima, K; Yasuno, S | 1 |
| Ferns, GA; Ghayour-Mobarhan, M; Lamb, DJ; Livingstone, C; Lovell, DP; Wang, T | 1 |
1 review(s) available for cetylpyridinium chloride anhydrous and Dyslipidemia
| Article | Year |
|---|---|
Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
Topics: Amyloid beta-Peptides; Apolipoprotein E2; Apolipoprotein E4; Apolipoproteins E; Cardiovascular Diseases; Dyslipidemias; Health; Heparan Sulfate Proteoglycans; Humans; Lipid Metabolism; Lipoproteins; Liver; Nervous System; Protein Isoforms; Receptors, LDL; Risk Factors | 2019 |
6 other study(ies) available for cetylpyridinium chloride anhydrous and Dyslipidemia
| Article | Year |
|---|---|
Acute changes in blood lipid profiles and metabolic risk factors in collegiate elite taekwondo athletes after short-term de-training: a prospective insight for athletic health management.
Topics: Atherosclerosis; Athletes; Blood Platelets; Body Composition; Cholesterol, HDL; Cholesterol, LDL; Dyslipidemias; Female; Health; Humans; Insulin Resistance; Lipids; Male; Martial Arts; Platelet Count; Prospective Studies; Risk Factors; Triglycerides | 2017 |
Cardiovascular Risk and Serum Hyaluronic Acid: A Preliminary Study in a Healthy Population of Low/Intermediate Risk.
Topics: Adult; Aged; Cardiovascular Diseases; Diabetes Mellitus; Dyslipidemias; Female; Health; Humans; Hyaluronic Acid; Hypercholesterolemia; Hyperglycemia; Male; Metabolic Syndrome; Middle Aged; Risk Factors | 2017 |
Healthy obesity and risk of accelerated functional decline and disability.
Topics: Activities of Daily Living; Adult; Body Mass Index; Chronic Pain; Comorbidity; Diabetes Mellitus, Type 2; Disability Evaluation; Dyslipidemias; Female; Health; Health Surveys; Humans; Hypertension; Insulin Resistance; Male; Middle Aged; Mobility Limitation; Musculoskeletal Diseases; Obesity; Risk Factors; Time Factors; Walking | 2017 |
Dynamics of human adipose lipid turnover in health and metabolic disease.
Topics: Adipocytes; Adipose Tissue; Adolescent; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Cell Size; Cellular Senescence; Child; Child, Preschool; Cohort Studies; DNA; Dyslipidemias; Health; Humans; Hyperlipidemia, Familial Combined; Lipid Metabolism; Lipolysis; Metabolic Diseases; Middle Aged; Nuclear Weapons; Obesity; Subcutaneous Fat; Time Factors; Triglycerides; Young Adult | 2011 |
Intra-abdominal fat area is a predictor for new onset of individual components of metabolic syndrome: MEtabolic syndRome and abdominaL ObesiTy (MERLOT study).
Topics: Adult; Blood Pressure; Body Mass Index; Dyslipidemias; Female; Health; Humans; Hyperglycemia; Intra-Abdominal Fat; Japan; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Obesity, Abdominal; Proportional Hazards Models; Risk Factors; Tomography, X-Ray Computed; Young Adult | 2012 |
Plasma antibody titres to heat shock proteins-60, -65 and-70: their relationship to coronary risk factors in dyslipidaemic patients and healthy individuals.
Topics: Antibodies; Chaperonin 60; Dyslipidemias; Female; Health; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Male; Middle Aged; Risk Factors | 2005 |